Fig. 2From: Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinomaResults of the questionnaire on the use of pazopanib in standard clinical practice according to patient profile (CrCl: creatinine clearance; ECOG: Eastern Cooperative Oncology Group: LVEF: left ventricular ejection fraction)Back to article page